Stay updated on Pembrolizumab & GM-CSF in Biliary Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & GM-CSF in Biliary Cancer Clinical Trial page.

Latest updates to the Pembrolizumab & GM-CSF in Biliary Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange Detected- Added a prominent operating-status notice due to funding lapse and a current operating status link, plus a reminder about visiting opm.gov for updates. - Updated version from v3.1.0 to v3.2.0.SummaryDifference3%
- Check19 days agoChange DetectedUpdate the page version from v3.0.2 to v3.1.0, reflecting a newer release metadata.SummaryDifference0.1%
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedUpgrade the page from v3.0.1 to v3.0.2 and remove the Back to Top link.SummaryDifference0.2%
- Check41 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2%
- Check48 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as detailed information on various biological factors and proteins. Notably, the revision number has been updated to v3.0.0, indicating a major change.SummaryDifference3%
- Check62 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
Stay in the know with updates to Pembrolizumab & GM-CSF in Biliary Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & GM-CSF in Biliary Cancer Clinical Trial page.